GUTS earnings: real EPS beat/miss history, analyst consensus Buy, P/E -0.44. Updated 2026-07-23.
Fractyl Health (GUTS) Research Hub
Fractyl Health (GUTS) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 0.64 USD (0.00%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.44, market cap 0.06B. This hub links to the full technical, earnings and options research available for GUTS.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.64 USD (0.00%) |
| 52-week range | 0.6311 USD – 1.02 USD |
| Trend regime | Range |
| 14-day RSI | 43 (Bearish) |
| Trailing P/E | -0.44 |
| Market cap | 0.06B |
| Dividend yield | 0.00% |
Available research for GUTS
Covered Call on GUTS: how it works, illustrative setup around the real 0.64 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on GUTS: how it works, illustrative setup around the real 0.64 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on GUTS: how it works, illustrative setup around the real 0.64 USD price, max profit/loss, breakeven and when to use it. Educational.
GUTS technical analysis: range, last 0.64 USD, RSI 43, 52w range 0.6311 USD–1.02 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is GUTS in?
Fractyl Health (GUTS) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is GUTS in an uptrend or downtrend?
As of 2026-09-11, GUTS is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is GUTS's trailing P/E ratio?
GUTS's trailing P/E is -0.44, with a market cap of 0.06B. See the earnings research page for full valuation detail.